Alzheimer’s drug lowers levels of protein known to cause disease, suggests study

The findings indicate scientists can alter the amount of tau – one of the proteins that cause Alzheimer’s – by silencing the messages from DNA that make the abnormal protein within each cell, with a drug called BIIB080 (MAPTRx).

Researchers say an Alzheimer’s drug lowers levels of harmful protein known to cause the disease (David Davies/PA)

A new genetic therapy for Alzheimer’s disease is safe and successfully lowered levels of the harmful tau protein known to cause the disease, a new study suggests.

Researchers say the findings are a “significant” step forward in demonstrating it may be possible to target the protein to slow, or potentially even reverse, the disease.